...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Financing Update
5
May 13, 2016 10:47AM
5
May 13, 2016 11:47AM

At the AGM, I think the IPO comments were regarding an RTO on the TSX rather than the Nasdaq.

I suspect they are delaying a webcast until they have significant events to discuss.

2
May 16, 2016 01:42PM
Share
New Message
Please login to post a reply